Literature DB >> 17487193

Rapid identification of unknown heteroplasmic mutations across the entire human mitochondrial genome with mismatch-specific Surveyor Nuclease.

Sylvie Bannwarth1, Vincent Procaccio, Veronique Paquis-Flucklinger.   

Abstract

Mitochondrial DNA (mtDNA) mutations are responsible for mitochondrial diseases in numerous patients. But, until now, no rapid method was available for the identification of unknown deleterious point mutations. Here, we describe a new strategy for the rapid identification of heteroplasmic mtDNA mutations using mismatch-specific Surveyor Nuclease. This protocol involves the following three steps: (i) PCR amplification of the entire human mitochondrial genome in 17 overlapping fragments; (ii) localization of mtDNA mismatch(es) after digestion of the 17 amplicons by Surveyor Nuclease; and (iii) identification of the mutation by sequencing the region containing the mismatch. This Surveyor Nuclease-based strategy allows a systematic screening of the entire mtDNA to identify a mutation within 2 days. It represents an important diagnostic approach for mitochondrial diseases that can be routinely used in molecular diagnostic laboratories.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17487193     DOI: 10.1038/nprot.2006.318

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  21 in total

1.  Mitochondrial DNA damage and repair in RPE associated with aging and age-related macular degeneration.

Authors:  Haijiang Lin; Haifeng Xu; Fong-Qi Liang; Hao Liang; Praveena Gupta; Anna N Havey; Michael E Boulton; Bernard F Godley
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

2.  DHPLC/SURVEYOR nuclease: a sensitive, rapid and affordable method to analyze BRCA1 and BRCA2 mutations in breast cancer families.

Authors:  Brunella Pilato; Simona De Summa; Katia Danza; Stavros Papadimitriou; Paolo Zaccagna; Angelo Paradiso; Stefania Tommasi
Journal:  Mol Biotechnol       Date:  2012-09       Impact factor: 2.695

3.  Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.

Authors:  Paula M Keeney; Caitlin K Quigley; Lisa D Dunham; Christina M Papageorge; Shilpa Iyer; Ravindar R Thomas; Kathleen M Schwarz; Patricia A Trimmer; Shaharyar M Khan; Francisco R Portell; Kristen E Bergquist; James P Bennett
Journal:  Hum Gene Ther       Date:  2009-08       Impact factor: 5.695

4.  Cell-free DNA in the urine of rats exposed to ionizing radiation.

Authors:  Serazhutdin A Abdullaev; Gulchachak M Minkabirova; Vladimir G Bezlepkin; Azhub I Gaziev
Journal:  Radiat Environ Biophys       Date:  2015-05-03       Impact factor: 1.925

Review 5.  Error correction in gene synthesis technology.

Authors:  Siying Ma; Ishtiaq Saaem; Jingdong Tian
Journal:  Trends Biotechnol       Date:  2011-12-28       Impact factor: 19.536

6.  Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients.

Authors:  Anita Kloss-Brandstätter; Georg Schäfer; Gertraud Erhart; Alexander Hüttenhofer; Stefan Coassin; Christof Seifarth; Monika Summerer; Jasmin Bektic; Helmut Klocker; Florian Kronenberg
Journal:  Am J Hum Genet       Date:  2010-12-10       Impact factor: 11.025

7.  Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas.

Authors:  Perumal Vivekanandan; Hubert Daniel; Matthew M Yeh; Michael Torbenson
Journal:  Mod Pathol       Date:  2010-03-12       Impact factor: 7.842

Review 8.  The cybrid model of sporadic Parkinson's disease.

Authors:  Patricia A Trimmer; James P Bennett
Journal:  Exp Neurol       Date:  2009-03-26       Impact factor: 5.330

9.  Mitochondrial DNA has a pro-inflammatory role in AMD.

Authors:  Bernard Dib; Haijiang Lin; Daniel E Maidana; Bo Tian; John B Miller; Peggy Bouzika; Joan W Miller; Demetrios G Vavvas
Journal:  Biochim Biophys Acta       Date:  2015-08-21

10.  Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance.

Authors:  Charles R Arthur; Stephanie L Morton; Lisa D Dunham; Paula M Keeney; James P Bennett
Journal:  Mol Neurodegener       Date:  2009-09-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.